• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

proventionbio

Going public, Provention Bio looks to tackle immune-mediated diseases

July 24, 2018 By Sarah Faulkner

Provention Bio

Shares in Oldwick, N.J.-based Provention Bio began trading today following the close of its $64 million initial public offering last week. The biopharmaceutical company, lead by co-founder & CEO Ashleigh Palmer, is developing a number of products that aim to prevent or stop the spread of immune-mediated diseases, including Lupus, Crohn’s disease and Type I diabetes. […]

Filed Under: Clinical Trials, Diabetes, Featured, Funding Roundup, Initial Public Offering (IPO), Pharmaceuticals, Wall Street Beat Tagged With: proventionbio

Provention Bio closes $64m IPO

July 20, 2018 By Fink Densford

Provention Bio

Provention Bio yesterday closed its initial public offering, raising approximately $63.9 million. Funds from the round will help support the Oldwick, N.J.-based company’s clinical-stage biopharmaceuticals that aim to prevent or intercept immune-mediated diseases. Provention Bio said that it expects shares of its common stock will begin trading on Nasdaq under the ticker symbol “PRVB” next […]

Filed Under: Business/Financial News, Featured, Initial Public Offering (IPO), Pharmaceuticals Tagged With: proventionbio

Provention Bio wants to stop Type I diabetes – with a vaccine

July 25, 2017 By Sarah Faulkner

Provention Bio

Before he co-founded Provention Bio, Ashleigh Palmer worked on inhaled nitric oxide for infants with respiratory failure. After the company was sold for $1.2 billion to a Baxter-led consortium, Palmer noticed there was apprehension about conducting clinical trials with neonates. He was concerned that the inhaled NO assets were slated to fall to the wayside. […]

Filed Under: Clinical Trials, Diabetes, Featured, Pharmaceuticals, Research & Development Tagged With: johnsonandjohnson, Juvenile Diabetes Research Foundation (JDRF), proventionbio

Provention Bio evaluates vaccine to prevent onset of T1D

July 18, 2017 By Sarah Faulkner

Provention Bio

Provention Bio said today that it licensed an enterovirus vaccine platform that it plans to evaluate as a way to prevent the onset of Type I diabetes by vaccinating against infection by a coxsackievirus B pathogen. Previous work has shown that CVB infection could be responsible for 50% of Type I diabetes cases worldwide, according […]

Filed Under: Clinical Trials, Diabetes, Featured, Funding Roundup, Pharmaceuticals Tagged With: Juvenile Diabetes Research Foundation (JDRF), proventionbio

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS